Your browser doesn't support javascript.
loading
Rivaroxaban compared with standard anticoagulants for the treatment of acute venous thromboembolism in children: a randomised, controlled, phase 3 trial.
Male, Christoph; Lensing, Anthonie W A; Palumbo, Joseph S; Kumar, Riten; Nurmeev, Ildar; Hege, Kerry; Bonnet, Damien; Connor, Philip; Hooimeijer, Hélène L; Torres, Marcela; Chan, Anthony K C; Kenet, Gili; Holzhauer, Susanne; Santamaría, Amparo; Amedro, Pascal; Chalmers, Elizabeth; Simioni, Paolo; Bhat, Rukhmi V; Yee, Donald L; Lvova, Olga; Beyer-Westendorf, Jan; Biss, Tina T; Martinelli, Ida; Saracco, Paola; Peters, Marjolein; Kállay, Krisztián; Gauger, Cynthia A; Massicotte, M Patricia; Young, Guy; Pap, Akos F; Majumder, Madhurima; Smith, William T; Heubach, Jürgen F; Berkowitz, Scott D; Thelen, Kirstin; Kubitza, Dagmar; Crowther, Mark; Prins, Martin H; Monagle, Paul.
Afiliación
  • Male C; Department of Paediatrics, Medical University of Vienna, Vienna, Austria. Electronic address: christoph.male@meduniwien.ac.at.
  • Lensing AWA; Bayer AG, Wuppertal, Germany.
  • Palumbo JS; Cancer and Blood Diseases Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA; Department of Pediatrics, University of Cincinnati College of Medicine, Cincinnati, OH, USA.
  • Kumar R; Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
  • Nurmeev I; Kazan State Medical University, Russia.
  • Hege K; Riley Hospital for Children at IU Health, Indianapolis, IN, USA.
  • Bonnet D; M3C-Necker Enfants malades, Université Paris Descartes, Sorbonne Paris Cité, Paris, France.
  • Connor P; The Noah's Ark Children's Hospital for Wales, Cardiff, UK.
  • Hooimeijer HL; Department of Hematology and Oncology, University Medical Center Groningen, Beatrix Children's Hospital, Groningen, Netherlands.
  • Torres M; Department of Hematology and Oncology, Cook Children's Medical Center, Fort Worth, TX, USA.
  • Chan AKC; McMaster Children's Hospital, Hamilton, ON, Canada.
  • Kenet G; Sackler Faculty of Medicine, Tel Aviv University, Tel Aviv, The Israeli National Hemophilia Center and Thrombosis Unit, and The Amalia Biron Thrombosis Research Institute, Sheba Medical Center, Tel Hashomer, Israel.
  • Holzhauer S; Charité University Medicine, Department of Paediatric Haematology and Oncology, Berlin, Germany.
  • Santamaría A; Haemostasis and Thrombosis Unit, Department of Haematology, University Hospital Vall d'Hebron, Barcelona, Spain.
  • Amedro P; Paediatric and Congenital Cardiology Department, M3C Regional Reference Centre, Montpellier University Hospital, PhyMedExp, INSERM, CNRS, Montpellier, France.
  • Chalmers E; Royal Hospital for Children, Glasgow, UK.
  • Simioni P; Thrombotic and Haemorrhagic Diseases Unit, Department of Medicine (DIMED), Padua University Hospital, Padua, Italy.
  • Bhat RV; Ann & Robert H Lurie Children's Hospital of Chicago, Feinberg School of Medicine, Northwestern University, IL, USA.
  • Yee DL; Baylor College of Medicine and Texas Children's Hospital, Houston, TX, USA.
  • Lvova O; Ural Federal University and Ural State Medical University, Yekaterinburg, Russia.
  • Beyer-Westendorf J; Department of Medicine I, Division of Haematology and Haemostaseology, University Hospital "Carl Gustav Carus" Dresden, and King's Thrombosis Service, Department of Haematology, King's College London, UK.
  • Biss TT; Department of Haematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust Newcastle Upon Tyne, UK.
  • Martinelli I; Fondazione IRCCS Ca' Granda - Ospedale Maggiore Policlinico, A Bianchi Bonomi Haemophilia and Thrombosis Centre, Milan, Italy.
  • Saracco P; University Hospital Città della Salute e della Scienza, Turin, Italy.
  • Peters M; Department of Paediatric Haematology, Emma Children's Hospital, University Medical Centres, Location Academic Medical Centre, Amsterdam, Netherlands.
  • Kállay K; Department of Paediatric Haematology and Stem Cell Transplantation, Central Hospital of Southern Pest, National Institute of Haematology and Infectious Diseases, Budapest, Hungary.
  • Gauger CA; Nemours Children's Specialty Care, Jacksonville, FL, USA.
  • Massicotte MP; Department of Paediatrics, University of Alberta, Edmonton, AB, Canada.
  • Young G; Children's Hospital Los Angeles, University of Southern California Keck School of Medicine, Los Angeles, USA.
  • Pap AF; Bayer AG, Wuppertal, Germany.
  • Majumder M; Bayer, Whippany, NJ, USA.
  • Smith WT; Bayer, Whippany, NJ, USA.
  • Heubach JF; Bayer AG, Wuppertal, Germany.
  • Berkowitz SD; Bayer, Whippany, NJ, USA.
  • Thelen K; Bayer AG, Wuppertal, Germany.
  • Kubitza D; Bayer AG, Wuppertal, Germany.
  • Crowther M; Department of Medicine, McMaster University, Hamilton, ON, Canada.
  • Prins MH; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, Netherlands.
  • Monagle P; Department of Clinical Haematology, Royal Children's Hospital, Haematology Research Murdoch Children's Research Institute, Department of Paediatrics, University of Melbourne, VIC, Australia.
Lancet Haematol ; 7(1): e18-e27, 2020 Jan.
Article en En | MEDLINE | ID: mdl-31699660
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tromboembolia Venosa / Rivaroxabán / Anticoagulantes Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Haematol Año: 2020 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Tromboembolia Venosa / Rivaroxabán / Anticoagulantes Tipo de estudio: Clinical_trials / Etiology_studies / Risk_factors_studies Límite: Adolescent / Child / Child, preschool / Female / Humans / Infant / Male Idioma: En Revista: Lancet Haematol Año: 2020 Tipo del documento: Article